• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION TRAPEASE PERMANENT VENA CAVA FILTER; THROMBECTOMY SYSTEMS (DQO)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION TRAPEASE PERMANENT VENA CAVA FILTER; THROMBECTOMY SYSTEMS (DQO) Back to Search Results
Catalog Number 466P306A
Device Problems Material Frayed (1262); Torn Material (3024)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/18/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).The device will not be returned for analysis.A device history record (dhr) review and additional information are pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, when the physician attempted to insert the accessory sheath into the patient, it could not be inserted.Then it was noted that it was frayed.Therefore, a new non-cordis device was used to complete the procedure.There was no reported patient injury.The device will not be returned for analysis.The patient's information was unknown.The target lesion was the femoral artery.The rate of stenosis was unknown.There were no damages or anomalies noted to the trapease and accessory devices, or the packaging.The devices were handled and prepped according to the instructions for use (ifu) a transfemoral approach was made.Vessel characteristics of the access site are unknown, such as if it was at a vein valve, stenosed, or tortuous.A trapease was attempted to be placed.The left femoral vein was punctured (it is unknown if there was difficulty during puncture) and sheath introducer (accessory for the trapease) was attempted to insert but it could not be inserted.The physician tried to insert the sheath but it got frayed.It is unknown what part of the sheath became frayed.It is unknown if the sheath was kinked/bent after attempted use.Therefore the trapease was changed to another new one (non-cordis).The procedure was finished successfully.There was no reported patient injury.The product was clinically used.
 
Manufacturer Narrative
Complaint conclusion: as reported, when the physician attempted to insert the trapease accessory sheath into the patient, it could not be inserted.Then it was noted that it was frayed.Therefore, a new non-cordis device was used to complete the procedure.There was no reported patient injury.The target lesion was the femoral artery.Vessel characteristics of the access site are unknown, such as if it was at a vein valve, stenosed, or tortuous.There were no damages or anomalies noted to the trapease and accessory devices, or the packaging.The devices were handled and prepped according to the instructions for use (ifu).A transfemoral approach was made.A trapease was attempted to be placed.The left femoral vein was punctured (it is unknown if there was difficulty during puncture) and sheath introducer (accessory for the trapease) was attempted to insert but it could not be inserted.The physician tried to insert the sheath but it got frayed.It is unknown what part of the sheath became frayed.It is unknown if the sheath was kinked/bent after attempted use.The device was not returned for analysis.Review of lot 15886599 revealed no anomalies during the manufacturing and inspection processes that can be associated with the reported complaint.The reported brite tip frayed/split/torn and insertion difficulty could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Based on the limited information available for review, factors contributing to the difficulty experienced by the customer could not be determined.It is possible that patient factors (skin, vessel characteristics at the insertion site) may have contributed to the difficulty experienced.The ifu states that ¿if strong resistance is met during any stage of the procedure, discontinue the procedure and determine the cause before proceeding.¿ neither the dhr nor the information available for review suggests a design or manufacturing related cause for the events reported; therefore, no corrective action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAPEASE PERMANENT VENA CAVA FILTER
Type of Device
THROMBECTOMY SYSTEMS (DQO)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL
Manufacturer Contact
cecil navajas
circuito interior norte #1820
juarez chihuahua 32580
MX   32580
7863133880
MDR Report Key5651163
MDR Text Key45057543
Report Number9616099-2016-00235
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K020316
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/18/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2016
Device Catalogue Number466P306A
Device Lot Number15886599
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/18/2016
Initial Date FDA Received05/12/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/09/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/13/2013
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-